HMG-CoA Reductase Inhibitors for Traumatic Brain Injury.


Journal

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
ISSN: 1878-7479
Titre abrégé: Neurotherapeutics
Pays: United States
ID NLM: 101290381

Informations de publication

Date de publication:
Oct 2023
Historique:
accepted: 09 06 2023
pmc-release: 01 10 2024
medline: 30 11 2023
pubmed: 23 6 2023
entrez: 23 6 2023
Statut: ppublish

Résumé

Traumatic brain injuries (TBIs) are associated with high morbidity and mortality due to both the original insult as well as the destructive biological response that follows. Medical management aims to slow or even halt secondary neurological injury while simultaneously laying the groundwork for recovery. Statins are one class of medications that is showing increased promise in the management of TBI. Used extensively in cardiovascular disease, these drugs were originally developed as competitive inhibitors within the cholesterol production pipeline. They are now used in diverse disease states due to their pleiotropic effects on other biological processes such as inflammation and angiogenesis. Preclinical studies, retrospective reviews, and randomized clinical trials have shown a variety of benefits in the management of TBI, but to date, no large-scale randomized clinical trial has been performed. Despite this limitation, statins' early promise and well-tolerated side effect profile make them a promising new tool in the management of TBIs. More bench and clinical studies are needed to delineate proper treatment regimens as well as understand their true potential.

Identifiants

pubmed: 37351829
doi: 10.1007/s13311-023-01399-9
pii: 10.1007/s13311-023-01399-9
pmc: PMC10684840
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1538-1545

Informations de copyright

© 2023. The American Society for Experimental Neurotherapeutics, Inc.

Références

J Clin Neurosci. 2017 Oct;44:143-147
pubmed: 28688622
Brain Inj. 2020 Aug 23;34(10):1367-1374
pubmed: 32790503
J Clin Med Res. 2013 Jun;5(3):168-73
pubmed: 23671542
J Neurotrauma. 2016 Oct 15;33(20):1809-1817
pubmed: 26959810
J Neurotrauma. 2004 Jan;21(1):21-32
pubmed: 14987462
JAMA. 2003 Apr 2;289(13):1681-90
pubmed: 12672737
J Mol Cell Cardiol. 2012 Jan;52(1):83-92
pubmed: 21968328
Hepatology. 2014 Aug;60(2):679-86
pubmed: 24700436
Brain Res. 2015 Mar 30;1602:1-8
pubmed: 25445996
Nat Med. 2000 Dec;6(12):1399-402
pubmed: 11100127
Brain Inj. 2014;28(2):211-26
pubmed: 24456059
Methods Find Exp Clin Pharmacol. 2003 Jul-Aug;25(6):457-81
pubmed: 12949632
Brain Inj. 2016;30(8):993-8
pubmed: 27119267
Science. 2001 Nov 9;294(5545):1354-7
pubmed: 11701931
Exp Neurol. 2007 Jul;206(1):59-69
pubmed: 17521631
J Neurotrauma. 2008 Aug;25(8):1011-7
pubmed: 18690806
Turk J Med Sci. 2016 Jan 05;46(1):1-5
pubmed: 27511325
Acta Neurochir Suppl. 2008;102:99-104
pubmed: 19388297
N Engl J Med. 1995 Feb 23;332(8):488-93
pubmed: 7830729
Transplantation. 1996 May 27;61(10):1469-74
pubmed: 8633373
JAMA Netw Open. 2021 Nov 1;4(11):e2135371
pubmed: 34807258
Lancet. 2012 Sep 22;380(9847):1088-98
pubmed: 22998718
Circulation. 1999 Jul 20;100(3):230-5
pubmed: 10411845
Epilepsia. 2015 Sep;56(9):1438-44
pubmed: 26332184
Neurol Clin. 2008 May;26(2):521-41, x
pubmed: 18514825
Am Heart J. 2014 Jul;168(1):6-15
pubmed: 24952854
Neurology. 2003 Jan 14;60(1):10-6
pubmed: 12525711
J Neurosci Res. 2005 Feb 1;79(3):340-50
pubmed: 15605375
J Neurochem. 2002 Jan;80(1):178-90
pubmed: 11796756
Brain Res. 2012 Nov 27;1486:121-30
pubmed: 23026078
Life Sci. 2007 Jul 4;81(4):288-98
pubmed: 17612572
J Neurotrauma. 2017 Feb 27;:
pubmed: 28006970
Lancet. 2015 Jan 24;385(9965):351-61
pubmed: 25262344
J Neurosurg. 2004 Nov;101(5):813-21
pubmed: 15540920
J Surg Res. 2020 Jan;245:367-372
pubmed: 31425877
CNS Drugs. 2016 Sep;30(9):791-806
pubmed: 27339615
Biomed Res Int. 2014;2014:910260
pubmed: 25013810
J Neurotrauma. 2016 Aug 15;33(16):1492-500
pubmed: 26542887
Am J Med. 2005 Jun;118(6):618-24
pubmed: 15922693
Mt Sinai J Med. 2009 Apr;76(2):163-72
pubmed: 19306386
Am J Cardiol. 1998 Feb 1;81(3):333-5
pubmed: 9468077
Neurocrit Care. 2017 Dec;27(3):430-446
pubmed: 28573388
Neurosurgery. 2011 May;68(5):1363-71; discussion 1371
pubmed: 21307798
Neuropsychology. 2009 Jan;23(1):20-39
pubmed: 19210030
J Neurochem. 2007 Apr;101(1):77-86
pubmed: 17241114
Clin Neuropharmacol. 1991 Jun;14(3):256-61
pubmed: 1906375
Nat Rev Drug Discov. 2005 Dec;4(12):977-87
pubmed: 16341063
Lancet Neurol. 2017 Dec;16(12):987-1048
pubmed: 29122524
J Head Trauma Rehabil. 2018 Nov/Dec;33(6):E68-E76
pubmed: 29385012
J Neurotrauma. 2004 Dec;21(12):1756-66
pubmed: 15684767
N Engl J Med. 2005 Jan 6;352(1):73-5
pubmed: 15635116
J Neurotrauma. 2007 Jul;24(7):1132-46
pubmed: 17610353
J Lipid Res. 2006 Jul;47(7):1339-51
pubmed: 16585781
Int J Mol Sci. 2014 Nov 10;15(11):20607-37
pubmed: 25391045
Arch Phys Med Rehabil. 2011 Aug;92(8):1211-9
pubmed: 21807140
J Neurosurg. 2013 Mar;118(3):669-75
pubmed: 23289819
Lancet Neurol. 2013 Jan;12(1):53-64
pubmed: 23177532
Brain Res Rev. 2007 Dec;56(2):443-71
pubmed: 17959252
J Pharmacol Exp Ther. 2005 Feb;312(2):786-93
pubmed: 15358814
J Neurosurg. 2004 Nov;101(5):822-5
pubmed: 15540921
J Neurosci. 2003 Dec 3;23(35):11104-11
pubmed: 14657168
JAMA Neurol. 2019 Aug 01;76(8):887-896
pubmed: 31107515
Nature. 1990 Feb 1;343(6257):425-30
pubmed: 1967820
J Neuroinflammation. 2017 Aug 23;14(1):167
pubmed: 28835272
J Cereb Blood Flow Metab. 2013 Jun;33(6):826-33
pubmed: 23443172
Lancet Neurol. 2007 Jan;6(1):29-38
pubmed: 17166799
J Neurotrauma. 2016 Mar 15;33(6):567-80
pubmed: 26541177
Ethiop J Health Sci. 2021 Jul;31(4):807-816
pubmed: 34703180
Am J Cardiol. 2017 Sep 1;120(5):774-781
pubmed: 28779871
Neurosurgery. 2009 Jul;65(1):187-91; discussion 191-2
pubmed: 19574841
J Lipid Res. 1992 Nov;33(11):1569-82
pubmed: 1464741
J Trauma. 2011 Oct;71(4):815-9
pubmed: 21986733
Neurology. 2000 Oct 24;55(8):1158-66
pubmed: 11071494
Alzheimers Res Ther. 2020 Mar 27;12(1):33
pubmed: 32220235
Neurosurgery. 2011 May;68(5):1172-85; discussion 1185-6
pubmed: 21307793

Auteurs

Kalman Katlowitz (K)

Department of Neurosurgery, Baylor College of Medicine, Houston, TX, 77030, USA. Kalman.katlowitz@bcm.edu.

Shankar Gopinath (S)

Department of Neurosurgery, Baylor College of Medicine, Houston, TX, 77030, USA.

Jovany Cruz Navarro (J)

Department of Neurosurgery, Baylor College of Medicine, Houston, TX, 77030, USA.

Claudia Robertson (C)

Department of Neurosurgery, Baylor College of Medicine, Houston, TX, 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH